Generic Estrace is used for treating conditions due to menopause (eg, hot flashes; vaginal itching, burning, or dryness), treating vulval or vaginal atrophy, and preventing osteoporosis (brittle bones). It is also used for estrogen replacement therapy after failure of the ovaries and to relieve the symptoms of breast cancer.
Generic Evista is used for treating and preventing osteoporosis (bone thinning) in women who are past menopause. It is also used to reduce the risk of invasive breast cancer in certain women who are past menopause.
Generic Premarin is used for treating certain symptoms of menopause (eg, hot flashes, vaginal dryness or itching). It is used to prevent osteoporosis (weak bones) after menopause in certain patients. It is also used in certain patients to treat low estrogen levels, prostate cancer or breast cancer.
Celiac Disease is Linked to Osteoporosis - Newswise (press release)
Celiac Disease is Linked to OsteoporosisNewswise (press release)Newswise — People with celiac disease are at risk for osteoporosis, according to physicians at Loyola University Health System (LUHS).
Better care to prevent falls and fractures will improve lives and save the NHS ... - dh.gov.uk
Daily MailBetter care to prevent falls and fractures will improve lives and save the NHS .
Osteoporosis Drug Delivery via Wireless Microchip - Medscape
Zee NewsOsteoporosis Drug Delivery via Wireless MicrochipMedscapeFebruary 17, 2012 — Researchers have conducted the first-in-human clinical trial of an implantable, wirelessly controlled microchip that can be programmed to deliver medication to patients with osteoporosis.
Microchip device delivers drug - Chicago Tribune
mobihealthnewsMicrochip device delivers drugChicago TribuneCHICAGO (Reuters) - An implantable microchip delivered osteoporosis medicine to a small group of Danish women, raising hope for a new kind of drug-delivery device that might allow patients to skip regular injections, researchers said.
Clinical AdvisorOsteoporosis Diagnosis, Prevention & TreatmentClinical AdvisorOsteoporosis affects approximately 10 million Americans, and another 40 million are at risk for the bone disorder.
